Literature DB >> 34971864

ESSM Position Statement "Sexual Wellbeing After Gender Affirming Surgery".

Müjde Özer1, Sahaand Poor Toulabi2, Alessandra D Fisher3, Guy T'Sjoen4, Marlon E Buncamper5, Stan Monstrey6, Marta R Bizic7, Miroslav Djordjevic7, Marco Falcone8, Nim A Christopher9, Daniel Simon10, Luis Capitán10, Joz Motmans11.   

Abstract

INTRODUCTION: Much has been published on the surgical and functional results following Gender Affirming Surgery ('GAS') in trans individuals. Comprehensive results regarding sexual wellbeing following GAS, however, are generally lacking. AIM: To review the impact of various GAS on sexual wellbeing in treatment seeking trans individuals, and provide a comprehensive list of clinical recommendations regarding the various surgical options of GAS on behalf of the European Society for Sexual Medicine.
METHODS: The Medline, Cochrane Library and Embase databases were reviewed on the results of sexual wellbeing after GAS. MAIN OUTCOMES MEASURE: The task force established consensus statements regarding the somatic and general requirements before GAS and of GAS: orchiectomy-only, vaginoplasty, breast augmentation, vocal feminization surgery, facial feminization surgery, mastectomy, removal of the female sexual organs, metaidoioplasty, and phalloplasty. Outcomes pertaining to sexual wellbeing- sexual satisfaction, sexual relationship, sexual response, sexual activity, enacted sexual script, sexuality, sexual function, genital function, quality of sex life and sexual pleasure- are provided for each statement separately.
RESULTS: The present position paper provides clinicians with statements and recommendations for clinical practice, regarding GAS and their effects on sexual wellbeing in trans individuals. These data, are limited and may not be sufficient to make evidence-based recommendations for every surgical option. Findings regarding sexual wellbeing following GAS were mainly positive. There was no data on sexual wellbeing following orchiectomy-only, vocal feminization surgery, facial feminization surgery or the removal of the female sexual organs. The choice for GAS is dependent on patient preference, anatomy and health status, and the surgeon's skills. Trans individuals may benefit from studies focusing exclusively on the effects of GAS on sexual wellbeing.
CONCLUSION: The available evidence suggests positive results regarding sexual wellbeing following GAS. We advise more studies that underline the evidence regarding sexual wellbeing following GAS. This position statement may aid both clinicians and patients in decision-making process regarding the choice for GAS. Özer M, Toulabi SP, Fisher AD, et al. ESSM Position Statement "Sexual Wellbeing After Gender Affirming Surgery". Sex Med 2022;10:100471.
Copyright © 2021 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gender Affirming Surgery; Gender Diverse; Gender Incongruence; Metaidoioplasty; Phalloplasty; Sexual Wellbeing; Transgender; Transsexual; Vaginoplasty

Year:  2021        PMID: 34971864      PMCID: PMC8847816          DOI: 10.1016/j.esxm.2021.100471

Source DB:  PubMed          Journal:  Sex Med        ISSN: 2050-1161            Impact factor:   2.491


INTRODUCTION

Human sexual behaviour is a complex phenomenon, both for trans and non-trans or cis individuals, orchestrated by the interaction between biological, psychological and social factors. General studies on sexual wellbeing show that having a poor physical health or a chronic illness has a negative impact on sexual wellbeing,, and that issues such as sex frequency, sexual pleasure and sexual satisfaction are strongly positively correlated with mental health.3, 4, 5, 6 With trans individuals, having an increased susceptibility to poor mental health outcomes due to a lack of social acceptance and/or access to care, sexual health outcomes are thought to be equally affected. Furthermore, for trans individuals who might be undergoing changes in body composition and perception to align these with their gender identity, specific challenges may arise making sexuality a delicate subject to deal with in counselling. Additionally, data on the significance of sex steroids with respect to sexual functioning and satisfaction in cis individuals10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 brings about the notion that Gender Affirming Medical Interventions (GAMI), such as hormone therapy and surgical interventions, might affect sexual functioning in trans individuals.

Studies on Sexual Wellbeing

Up to now, studies on sexual wellbeing of trans individuals are scarce or often based on a small population. Current literature mostly pays attention either at sexuality prior to GAMI,, or on the combined effect of hormonal and surgical interventions on sexual wellbeing.24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 Data on sexuality before Gender Affirming Surgery (GAS) from a multicentre prospective study in four European gender identity clinics (Amsterdam, Ghent, Hamburg, Florence, and Oslo) found no difference in frequency of the involvement of the genitalia and appraisal of genital sensation during sexual contact among individuals AMAB and AFAB (Assigned Female at Birth), prior to (GAS). In a small clinical study, about half of all trans individuals prior to genital surgeries, rated their sexual life as “poor or dissatisfied” or “very poor or very dissatisfied.” Receiving hormone treatment, experiencing negative feelings, and having a partner, however, were found to relate to better subjective perceptions of sexual quality of life. Other studies also report on the improved sexual functioning after GAS. The only available prospective study on this matter reported a significant decrease in sexual distress in trans individuals under hormone treatment. Despite the perceived detrimental effects of hormone treatment on sexual function - especially in individuals AMAB (Assigned Male at Birth) - sexual distress indeed is reduced after starting hormone treatment, and sexual wellbeing might significantly improve by minimizing the incongruence between one's body and gender identity.

Defining Sexual Health in Treatment Seeking Trans Individuals

Although sexual wellbeing is considered as an important aspect of quality of life, and recent studies show considerable improvement of quality of life after GAMI and GAS,38, 39, 40 little information is available on this subject in trans individual after GAS. This position paper uses ‘sexual wellbeing’ as the core concept of interest. The first written definition of sexual wellbeing originates from 2014 by Byers and Rehman, and Özer et al modified this definition in the scope of treatment seeking trans individuals in 2021. Sexual wellbeing in this position statement is a combination of sexuality, enacted sexual script, sexual activities, sexual relations, sexual response cycle, genital function, sexual function, sexual pleasure, sexual satisfaction and quality of sex life.

Aim

The European Society for Sexual Medicine expressed the need for a position statement on sexual wellbeing after GAS, to supplement the existing World Professional Association for Transgender Health Standards of Care, which lacks data on the effects of GAMI specifically on sexuality and sexual wellbeing. This position statement is a continuation on the previous European Society for Sexual Medicine (ESSM) Position Statement on “hormonal management of adolescent and adult trans people”. The adjective ‘trans’ is used here in line with the previous ESSM Position Statement on “hormonal management of adolescent and adult trans people”, to refer to both binary and gender diverse individuals. This position statement therefore does not focus on differences in sexual health outcomes between binary-oriented or non-binary trans individuals, but is aimed at reviewing the available evidence on sexual wellbeing following GAS. The position statement wishes to provide clinicians who specialize in trans-related care with recommendations about the impact of various GAS on sexual wellbeing in treatment seeking trans individuals, on behalf of the ESSM.

Methodology

This position statement aimed at providing results on sexual wellbeing following various gender affirming surgeries, based on the results from a systematic literature review, divided into four main sections: Somatic and General Requirements before GAS, Sexual Wellbeing after GAS (studies who did not specify in gender or surgery when presenting results of sexual wellbeing), Feminizing GAS and Masculinizing GAS, each with the specific surgical procedures and their effects on sexual wellbeing. The ESSM selected the authors based on their long-standing clinical experience and scientific involvement in specific areas of trans-related healthcare. A multidisciplinary approach was established by involvement of physicians from various specialties, including: endocrinology, oral and maxillofacial surgery, urology, plastic and gender surgery, sociology and sexology. The search strategy was developed with aid from a research librarian of the Amsterdam University Medical Center. Relevant papers were sourced from the Medline, EMBASE, and Cochrane Library electronic databases from May 2017 until April 2020. Keywords and index terms, including applicable MeSH and Entree terms, were applied to each database. Search terms were generated under two broad headings - ‘gender incongruence’ and ‘sexual wellbeing’ –to create a wide scope on the subject, and were subsequently narrowed down to sexual wellbeing after GAS. The following MeSH terms were applied to the Medline database: sex reassignment procedures; gender dysphoria; transgender persons; transsexualism; gender incongruence; gender affirming; trans women; trans men; sexual behaviour; coitus, courtship; masturbation; orgasm; dyspareunia; intercourse; copulation; penetration; lubrication; sexual; sensation; pain; arousal; desire; pleasure; satisfaction; dysfunction; wellbeing; relation; behaviour; activity and quality of sex life were applicable for MeSH terminology. Literature was selected, discussed among the authors and combined with their multidisciplinary knowledge and clinical expertise to establish the statements. The overall quality of evidence of the literature was low, most recommendations of this position statement are therefore low in Level of Evidence. The statements that are strongly recommended are phrased as “should” and suggestions, phrased as “is advised to” or “may”. The statements were formed after consensus of all the authors. Details on the literature search, eligibility and inclusion, data extraction and quality assessment are provided in Supplement 1. An overview of the results on sexual wellbeing following various gender affirming surgeries can be accessed through Table 1-5,7.
Table 1

Sexual wellbeing following gender affirming surgery

StudyDesignSample sizeAge rangeSexual TopicsMethods/ToolsOutcomes regarding Sexual Wellbeing
Cohen-Kettenis et al 1997Sexual Reassignment of Adolescent63Follow-up study49 AMAB20 AFAB19–27Sexual activity, intercourse, orgasm, relationship, masturbation, satisfaction with sex lifeSemi-structured interviewSexually active: n = 13Orgasm: 77% No partner at time of interview or had never had one: 57%Masturbation: 50% < 1/mo or never, 43% >1/mo; AMAB decrease in frequency, AFAB no change or increase Sexual satisfaction: 71% satisfied, 14% neutral view, 14% were dissatisfied
Jarolim et al 2000Surgical conversion of genitalia65Outcome meassure452 AMAB30 AFAB17–51Lubrication, orgasm, clitoral activityChart reviewVaginoplasty (n = 29):Sexual stimulation leads to production of urethral secretions which served as natural lubrication.Enabled coitus with orgasmMetoidioplasty (n = 28):Preserved erotogenic clitoral activity
Johansson et al 2010A Five-Year Follow-Up69Follow-up study425 AMAB17 AFAB18–60Relationships, sexual orientation, sex life, sexual impairmentSemi-structured interview, self-developed questionnaireSexual impairment after GAS: 5% AMABSex life: 70% better, 25% unchanged, 5% worsenedPartner relations: 62% better, 30% unchanged, 8% worsened
Kuhn et al 2011Vaginal prolapse, pelvic floor70Follow-up study452 AMAB3 AFABNo dataSexual activity: satisfaction, frequencySheffield prolapse questionnaireStable relationship: 71% 75% considered sex life to interfere to some degree with enjoyment of life (better and/or worse)Most were sexually satisfied and had sex on a regular basis
Lief et al 1993Orgasm in the postoperative61Outcome meassure414 AMAB9 AFAB27–63Frequency of sex (not restricted to coitus, orgasmic capacity, reasons for anorgasmia, sexual satisfaction, sexual preferenceSelf-developed questionnaireAMABOrgasm: 10 anorgasmic, 10/14 Orgasmic before, 8 lost capacity, 4/14 anorgasmic before, 2 gained capacity Reasons for anorgasmia: dissatisfied with vaginal depth or cosmesis Frequency of sex: 75% increaseSexual satisfaction: 9/14 increase in satisfactionAFABOrgasm: 7/9 Orgasmic, through masturbation, intercourse, and oral sex. 6 anorgasmic before: 4 gained capacitiesReasons for anorgasmia: dissatisfied with masculinity level of body Frequency of sex: 100% increaseSame people reporting being orgasmic report being sexually satisfied. Sexual satisfaction: 6/9 increase in satisfaction
Lobato et al 2006Follow-Up of Sex Reassignment68Follow-up study418 AMAB1 AFAB18–47Satisfaction with sexual experience, partnerships, and relationship with family members, sexually active, frequency of sex, pleasurability of sex.Self-developed questionnaireSexually active: 95%More frequent sex: 64.7% Pleasurability of sex: 83.3% PartnershipInitiating and maintaining relationship easier post SRS: 64.7%Relationship pre-op: 52.6%Relationship post-op: 73.7%Satisfaction with sexual experiencepoor or very poor post-op: 11.2%Improvement of sexual experience post-op: 83.3%
Lothstein et al 1980The postsurgical transsexual71Group comparison / Follow-up study48 AMAB6 AFAB21–42Sexual adjustment andfunctioning, improvement sex life, sexual activity, number of sexual partners, orgasm, sexual behaviour, partneringSelf-developed questionnaireAMABImprovement sex life 67%Sexual activity & number of sexual partners: no increase Orgasm: 2 ejaculatory sensationsSexual behaviour: more flexible and spontaneous (engaging more frequently in oral, anal, and vaginal intercourse)Partnering: tended to seek out new partners, 64% no relationship AFABImprovement sex life 67%Sexual activity & number of sexual partners: no increase Partnering: kept the same partners, 64% no relationship
Rakic et al 1996 The outcome of sex reassignment66Follow-up study422 AMAB10 AFAB19–47Orgasm, number of sex partners, sexual activity, satisfaction with relationshipsSelf-developed questionnaire: 'Adjustment to Sex Reassignment Surgery'Relationship satisfaction: 87%Sexual partner: AMAB 23%, AFAB 80%Several sexual partners: AMAB 50%Orgasm: 50%
Selvaggi et al 2007 Genital sensitivity after sex reassignment33Outcome meassure430 AMAB27 AFABNo dataOrgasm, sensitivityInterview and physical examination: Semmes-Weinstein, vibration tests (biothesiometer)The reconstructed genitalia obtaintactile and erogenous sensitivityOrgasm: AMAB 85%, AFAB 100%
Smith et al 2001Adolescents With Gender Identity Disorder64Group comparison / Follow-up study47 AMAB13 AFAB15–19Orgasm, relationship status, sexual orientation, intercourse, sexual functioningSelf-developed questionnaire, Utrecht Gender Dysphoria Scale (UGS), Body Image Scale (BIS)Sexual partner: 10 patientsSatisfaction with sex life: 1 FM was dissatisfied (could not have intercourse with a “normal” penis) Several AFAB: difficult to livewithout a penisknow their potential sexual partner well. Masturbation: AMAB –>decrease in masturbation frequency, AFAB–> increase or no change. Orgasms: 69%Sexual orientation: stayed compatible
Sorensen 1981A follow-up study60Outcome meassure48 AFAB30–60Intercourse, sexual satisfaction, masturbation, orgasm, sensitivity, ability to perform intercourse, importance of sexual activity, painStructured interviewSexual partner: all patientsSexual satisfaction: only from clitoris (all); 5 satisfactory, 3 unsatisfactoryMasturbation: all, >2 a wkOrgasm: allIntercourse: 2 with phalloplasty with rib, but with pain, 6 with dildoImportance of sexual activity: essential in a life with a partner to allPain: during intercourse in the 2 patients with phalloplasty from rib
Tsoi et al 1993Follow-up study of67Outcome meassure445 AMAB36 AFAB20–36Satisfaction with: sexual activities, organ functioning, sex status, sex organSemi-structured interview, self-developed questionnaireGood or satisfactory sexual activity: MtF 64% vs FtM 61% Good or satisfactory sex organ function:MtF 91% vs FtM 39% Good or satisfactory sex status:MtF 95% vs FtM 81%Good or satisfactory sex organ:MtF 91% vs FtM 39%
van de Grift et al 2017 A longitudinal study62Follow-up study421 AFABMean 40.1 ySexual activity (type of activity), sexual preference and change in preference, partnering, sexual satisfactionSelf-developed questionnaire, chart review, Body Image Scale (BIS)Female partner 63,2%Male partner 10,5%Single 26,3%Sexual function: metoidioplasty higher sexual satisfaction Postop sexual activity: more masturbation and sexual activity, genitals more freq used (31% vs 78%)More pleasure, confidence, passive roleChanged sexual orientation (“exclusively to men” to “primarily to women”). Grade for sex life: 5.5 of 10 (SD 2.6) à “impossibility to penetrate/no erection prosthesis”, “not sexually active”, “penile size/sensation” and “partner issues”
Wierckx et al 2011 Quality of life and26Follow-up study449 AFAB22–54Relationship status, sexual preference, sexual activities (frequency, type of activity, pain), sexual wellbeing, masturbation, sexual satisfaction, orgasm, arousalSelf-developed questionnaireTreatment phase differed within the groupRelationship 63,3%Attracted to females 85,7%Partner: heterosexual woman 77,4%Frequency of sex:Never 22,2%1-2/month 48,1%Several times a week 29,6%Sex satisfaction: (very satisfied) 64,2%Erection prosthesis (n = 32)Frequency of masturbation:Less than monthly- dailyAroused easily: majorityOrgasm through masturbation: majorityOrgasm by intercourse: majorityChange in orgasmic feeling: 58,3%
Table 5

Sexual wellbeing following metoidioplasty

StudyDesignLoESample sizeAge rangeSexual TopicsMethods/ToolsOutcomes regarding Sexual Wellbeing
Djordjevic et al 2013Comparison of Two Different Methods146Group comparison / Follow-up study4207 AFAB18–62Neo-phallic dimensions, erection ofthe clitoris, sensation, sexual arousal, masturbation, orgasm, sexual intercourseChart reviewLength of neophallus ranged from 4 cm–10 cm.Majority: pleased with the aesthetic appearance. All: erection of the clitoris and completely preserved sensationNone: problems or difficulties in sexual arousal, masturbation, or orgasms. Patients who reported sexual intercourse with partners: length of the neophallus was inadequate for full penetration
Djordjevic et al 2009Metoidioplasty as a Single189Outcome measure482 AFAB18–54Erectionof the clitoris, sensationChart reviewAll: erection of the clitoris and completely preserved sensation
Djordjevic et al 2018Novel surgical techniques in193Outcome measure4694 AFAB18–62Erection, sexual arousal, masturbation, orgasm, neo-phallic sensation (tactile, erogenous), sexual intercourseRetrospective chart reviewMajority: pleased with the aesthetic appearance. All: erection of the clitoris and completely preserved sensationNone: problems or difficulties in sexual arousal, masturbation, or orgasms. Patients who reported sexual intercourse with partners: length of the neophallus was inadequate for full penetration
Stojanovic et al 2017 One-Stage Gender-Confirmation Surgery187Outcome measure4374 AFAB18–43Sexual function, quality of erection, sexual arousal, erogenous sensationChart reviewMajority: complete satisfaction with appearance, overall complete sexual satisfaction and always experienced orgasm during masturbation.All: good quality of erection, sexual arousal, and completely preservederogenous sensation.
Takamatsu et al 2009Labial ring flap195Outcome measure443 AFAB18–33Sensitivity, intercourseChart reviewOne patient: intercourse with his female partner.No complaints of a reduction of erogenoussensation on the clitoral glans.
Van de Grift et al 2019Transmen's Experienced Sexuality196Cross sectional study438 AFABAverage 40 (SD 10)Arousability, sexual sensation, sexual pleasure, interest in sex, sexual initiative, orgasmic capacity/intensity, satisfaction with genital appearance, satisfaction with sexual functioning/relationships, sexual orientation, use of genitals during sexual contact, the influence of GAS on sexual outcomesCustom questionnairesNot specific for metaidoioplastyMajority: sexually active.Areas of improvement aftersurgery: use and enjoyment of both chest and genitals, arousability, sexual interest,and pleasure. Genital GAS positively impacts transmen's sexuality, issues with genital sensation or penetration may exist
Vukadinovic et al 2014The Role of Clitoral Anatomy197Outcome measure497 AFAB18–41Sexual arousal, masturbation, orgasm, ability to perform penetration, sexual activity (type of activity), quality of erection, erogenous sensation, sexual satisfactionBiographical Questionnaire for Transsexuals and Transvestites, self-developed questionnaireMajority: complete satisfaction with appearance, overall complete sexual satisfaction and always experienced orgasm during masturbation.All: good quality of erection, sexual arousal, and completely preservederogenous sensation.Patients who reported sexual intercourse with partners: length of the neophallus was inadequate for full penetration
Table 7

Sexual wellbeing following phalloplasty

StudyDesignLoESample sizeAge rangeSexual TopicsMethods/ToolsOutcomes regarding Sexual Wellbeing
Bettocchi et al 2005 Pedicled pubic205Outcome measure485 AFAB19–54Possibility to have penetrativesexual intercourseChart reviewPenetrative sex:16 without penile prosthesis17 with prosthesis (n = 8 malleable; n = 9 Dynaflex)6 lost malleable prosthesis through skin erosion
Djordjevic et al 2018 Novel surgical193Outcome measure4694 AFAB18–62Erection, sexual arousal, masturbation, orgasm, neo-phallic sensation (tactile, erogenous), sexual intercourseRetrospective chart reviewMetaidoioplasty:None reported difficulties or problems related to sexual arousal, masturbation or orgasmPhalloplasty:Erogenous sensation based on clitoral stimulation in allNone reported problems or difficulties in sexual arousal, masturbation or orgasmsSexual intercourse with complete penetration was totally adequate in all with penile implants
Falcone et al 2018 Outcomes of220Outcome measure4247 AFAB21–69Phallic sensation, sexualintercourse, orgasm, partner satisfactionChart review, Self-developed questionnaireSatisfactory phallic sensation: 83%. Penetrative sexual intercourse: 77% Orgasm: 61% Partner satisfaction: 60%
Fang et al 1999 Phalloplasty in219Outcome measure322 AFABNo dataErotic sensation of the clitoris, neophallus sensation, orgasm, masturbation, intercourseChart reviewAll preserved clitorises had erotic sensationErotic sensation on neophallus: 8 (shaft, hypothesis: coapted forearm cutaneous nerves to ilioinguinal and iliohypogastric nerves)Orgasm by masturbation the neophallus only: 1 (pudendal nerve anastomosis)Regular sex: 9 Orgasm during intercourse: 9Sexual performance: satisfactory 9
Garaffa et al 2010 Total phallic198Outcome measure4115 AFAB20–55Neo-phallus sensation, sexual activitySelf-developed questionnaireComplete phallus sensation: 71.5%Sensation within neourethra: 14,7%Insensate phallus: 6%Recent surgery too early to assess 5,2%Phalluses that were lost: 2,6%
Garcia et al 2014 Overall satisfaction221Outcome measure35 AFABM 35.1 (SD 2.23)Erogenous sensation, orgasm, masturbationInterviewSP: Suprapubic Phalloplasty 10RAP-: Radial Artery free flap Phalloplasty without nerve anastomosis 5RAP+: Radial Artery free flap Phalloplasty with nerve anastomosis 10Orgasm pre-op:SP: 9 of 10RAP -: 4 of 5RAP +: 7 of 10Orgasm post-opSP: allRAP -: allRAP +: 8 of 10Orgasm with direct stimulation of buried clitoris:SP: allRAP -: allRAP +: 4 of 6masturbate with phallusSP: 9 of 10RAP -: allRAP +: 9 of 10diminished orgasm after penile prosthesis: noneregret of surgery: none
Leriche et al 2008 Long-term outcome216Outcome measure456 AFAB20–44Cutaneous sensitivity, erogenous sensitivity, sexual satisfaction, satisfactory sexual intercourse with penetrationSelf-developed questionnaireCutaneous sensitivity of the phalloplasty: 83% Erogenous sensitivity: 9%Sexual satisfaction (penetration with penile implant): 51%
Monstrey et al 2009 Penile reconstruction202Outcome measure4280 AFAB, 7 men with various conditionsNo dataSensitivity, improvement in sexuality, orgasm, ability to perform penetration.Chart reviewTactile sensitivity: 100%Improvement in sexuality: 80%Sexually active: 100%Explantation rate erection prosthesis: 44%Sexual intercourse with penetration: 80%
Noe et al 1974 The surgical construction (230)Outcome measure412 AFABNo dataAbility to perform penetrative sex, orgasmChart reviewIntercourse: 10 of 12Orgasm: 9 of 12
Papadopulos et al 2001 Usefulness of free214Outcome measure424 AFABNo dataIntercourse, phallic sensitivity, painSelf-developed questionnaire, clinical and radiologic examinationQuestionnaire score:2 = excellent; 1 = acceptable; 0 = poorSensibility:Free forearm flap: 1,41Free fibula flap: 0,66Intercourse:Free forearm flap: 0,83Free fibula flap: 2Pain:Free forearm flap: 1,41Free fibula flap: 1,5
Ranno et al 2007 Neo-phalloplasty with212Cross-sectional study418 AFAB24–38Contractile power (measured and asked)Clinical examination of phallic contraction power (measurement of weight lifted and electromyography)"Paradox erection": 18Neo-phallus length (relaxed): 7–17 cm (mean 12.2 cm)Circumference (relaxed): 13–20 cm (mean 13.7 cm)Contract the muscle: all Average length reduction: 3.08 cm Average circumference enlargement: 4 cm
Ranno et al 2008 An objective211Outcome measure422 MtFNo dataIntercourse, penile dimensions (relaxed and contracted)Self-developed questionnaire, clinical examinationSexual intercourse without the need for prosthesisSuccessful contraction when 2 cm shortened with average weight 1129 gr
Schaff et al 2009 A new protocol215Outcome measure437 AFABNo dataIntercourse (and it's quality), sensationSelf-developed questionnaire, chart reviewFibula flap, sexual intercourse:Excellent: 100%Sensibility minor to forearm flap: 83,3%
Van de Grift et al 2019 Transmen's experienced196Cross sectional study438 AFABAverage 40 (SD 10)Arousability, sexual sensation, sexual pleasure, interest in sex, sexual initiative, orgasmic capacity/intensity, satisfaction with sexual functioning/relationships, sexual orientation, use of genitals during sexual contact, the influence of GAS on sexual outcomesCustom questionnairesSexual partner: 78%Sexual attraction: mainly womenUse of chest during sex: 40%Use of genitals during sex: 78%Satisfaction with sexual function:Metaidoioplasty: 63,5%Phalloplasty: 28%Arousability: ↑32%; = 65%; ↓3%Sexual sensation: ↑45%; = 39%; ↓16%Sexual pleasure: ↑40%; = 47%; ↓13%Interest in sex: ↑39%; = 45%; ↓16%Sexual initiative: ↑26%; = 58%; ↓16%Orgasmic intensity: ↑21%; = 52%; ↓23%Orgasmic capacity: ↑18%; = 52%; ↓26%
Vesely et al 2007 New technique217Outcome measure422 AFAB24–38Ability to have sexual intercourseSelf-developed questionnaireSexual intercourse: 42% Muscle movement: 100% to stiffen the penis and/or move the penis during sexual intercourse Penetration, but too short to keep inside: 11%No sexual activity: 16%Penetration not possible: 31% (too wide, too small, or too soft)
Wierckx et al 2011 Quality of life and26Follow-up study449 AFAB22–54Relationship status, sexual preference, sexual activities (frequency, type of activity, pain), sexual wellbeing, masturbation, sexual satisfaction, orgasm, arousalSelf-developed questionnaireSexual orientation: Attracted to females: 42Bisexual: 2Attracted to males: 5Relationship: 31 of 49Gender of partner: Heterosexual woman: 24Homo/bisexual woman: 4Homo/bisexual man: 1AMAB transsexual: 2Freq sexual activities: 1-2/month: 48%Several times weekly: 30%Sexual satisfaction: (Very) satisfied: 64%Use of clitoris during coitus: Touching: before: 12,8% after: 13%Stimulation: before: 34% after: 38,3%Use of vagina during coitus: Touching: before: 5,8% after: 11,4%Penetration: before: 25,5% after: 11,4%Results with vs without erection prosthesis:Freq of masturbation: (More than) weekly: 64,5% vs 30,8% Freq of easy arousal: Half of time: 45,2 vs 53,8Orgasm through masturbation: (Almost) always: 67,9% vs 58,3%Orgasm through coitus: (Almost) always: 38,9% vs 37,5%Change in orgasmic feeling: 64,3% vs 58,3%
Wierckx et al 2011 Sexual desire213Outcome measure345 AFAB22–54Sexual desire, frequency of sexual activity and masturbation, sexual satisfaction with the current partnerThe Dutch version of the Sexual Desire InventorySexual desire after GAS: (Much) higher: 32 No change: 11Decrease: 1Nor willing to answer: 1Satisfaction with sexual life: 64% Neutral 18%Unsatisfied: 18%
Zuckerman et al 2015 Penile prosthesis223Outcome measure415 AFAB16 Cis menM 35.6Sexual activityChart reviewSexually active post-implant: 85%

AFAB = assigned female at birth (transmasculine individual, trans man); AMAB = assigned male at birth (transfeminine individual, trans woman); LoE = level of evidence (oxford centre for evidence-based medicine 2011); MRKHS = mayer rokitansky kuster hauser syndrome.

Sexual wellbeing following gender affirming surgery

Somatic and General Requirements Before GAS

Statement #1 The gender surgeon should be aware of the effects of smoking and BMI when considering (genital) GAS. (Level I Grade A) Statement #2 The gender surgeon should engage in shared decision making and counsel the patient on expectation management, including expected sexual outcomes, prior to GAS (Level II Grade D) Statement #3 The gender surgeon is advised to collaborate with sexologists and pelvic floor physical therapists, trained on trans related health care, if available (Level IV Grade D)

Evidence

The surgeon and anaesthesiologist are tasked with assessing the general health status, perioperative risk, and contraindications as per the American Surgical Association physical status classification system, for individuals requesting surgery., Patients should be advised on smoking cessation and ideal weight for surgery, that is, a BMI between 18–30 kg/m2, prior to genital GAS.46, 47, 48 The eventual decision for surgery in patients outside of the ideal BMI range falls upon the surgical and anaesthesiology team and should not be considered a hard Contra-Indication. Hormone therapy may adversely affect fertility in both AFAB and AMAB individuals, while GAS may terminate potential for reproduction. Fertility preservation that is, cryopreservation of semen or oocytes, embryos or ovarian tissue- may aid in facilitating future parenting options. The choice between various surgical techniques for GAS is dependent on patient preference, patient anatomy and health status, and the surgeon's skillset. Choices are increasingly being made through shared decision-making. The surgeon should inform the patient on the techniques available, their advantages and disadvantages, limitations with producing ‘ideal’ results and possible risks and complications.52, 53, 54 How the surgeon presents surgical options, risks and benefits is of great importance. The surgeon should preferably present photos of their previous work and provide data on their complication rate. Little has been published on postsurgical regret in regard to functional outcomes and complication rate. Lawrence, however, found that less complications and better functional results after vaginoplasty were associated with less postsurgical regret.,

Sexual Wellbeing After Gender Affirming Surgery

Gender Affirming Surgery (GAS) is an umbrella term for a variety of surgical procedures. It is important to note that trans individuals may or may not adhere to a standard linear progression from hormone treatment to surgical procedures. Sexual motivations may influence some individuals to prefer surgical interventions without prior hormone treatment, or opt out of some surgical procedures. The outcomes on sexual wellbeing following GAS are found in Table 1. Fourteen studies reported on general sexual wellbeing following GAS, without specifying what kind of procedure was performed or how the participants identified gender-wise, mainly focusing on sexual activities, erogenous sensation, orgasm and sexual satisfaction. Frequency of sexual activities increased after both hormonal and surgical treatment.,60, 61, 62 Frequency of masturbation, however, was decreased in AMAB individuals and remained unchanged or increased in AFAB individuals., Every patient experienced postsurgical tactile erogenous, to some extent. Every AFAB individual and 85% of AMAB individuals were able to reach orgasm, either through masturbation or intercourse.,,,,, Orgasm after GAS was experienced more frequently by both AMAB and AFAB individuals, less frequently by AMAB individuals, than by AFAB individuals. Most AMAB individuals were satisfied with GAS, reporting sexual satisfaction with the possibility of penetrative sex, and being partnered. Initiating and maintaining intimate relationships became easier postoperatively., Limited sensitivity and absence of erectile function after phalloplasty decreased sexual satisfaction in AFAB individuals. Phalloplasty was not found to be a critical factor in reaching orgasm or sexual satisfaction, difficulties in engaging in new sexual contacts, however, may have been a factor preoperatively., The strongest motivation to pursue penile surgery was confirmation of one's identity. Postsurgical aesthetics and functionality were satisfactory, including the ability to void while standing. Disappointment following GAS resulted because of a decrease in sex drive, not being partnered or having non-functional genitalia. Advice regarding postsurgical care and follow-up were provided by two studies. Kuhn et al concluded that pelvic floor symptoms involving the bladder, bowel, and sexual function may occur in AMAB individuals. Lothstein et al advised counselling and psychotherapy prior to surgery and continued follow-up after completing GAS to improve sexual wellbeing.

Surgical Procedures for Feminizing GAS

This section addresses different types of feminizing GAS, with their respective results regarding sexual wellbeing.

Orchiectomy-Only

Statement #4 The gender surgeon is advised to consider orchiectomy-only as a viable surgical option for trans individuals AMAB (Level IV Grade D) Statement #5 The gender surgeon should counsel the trans individual AMAB on the expected effects on sexual wellbeing prior to orchiectomy (Level II Grade A)

Evidence

Indications include patient preference- in not opting for vaginoplasty- and failing at meeting somatic requirements for anti-androgen use or vaginoplasty (see: somatic requirements before GAS). Orchiectomy does not provide surgical consequences for future vaginoplasty, therefore can also be performed while waiting for a future vaginoplasty. Testosterone levels below 20 ng/dL (0.7 nmol/L) have been reported in patients following orchiectomy, patients should be counselled on possible adverse effects of low testosterone levels on sexual wellbeing.

Sexual Wellbeing After Orchiectomy

We found no studies on sexual wellbeing in trans individuals AMAB after orchiectomy-only.

Vaginoplasty

Statement #6 The gender surgeon should provide trans individuals AMAB the penile-inversion technique as the vaginoplasty of choice (Level IV Grade C) Statement #7 The gender surgeon should be capable to offer alternatives to the penile-inversion technique, in trans individuals AMAB, like: skin grafts or bowel segments to create adequate vaginal depth in cases of penoscrotal hypoplasia and inadequate penile skin length (Level IV Grade C) Statement #8 The gender surgeon is advised to counsel on vulvoplasty (or zero-depth vaginoplasty) when this is recommended by health care professionals or requested by the patient, to reduce possible future regret in trans individuals AMAB (Level IV Grade D) Statement #9 The gender surgeon should counsel trans individuals AMAB on expected sexual outcomes, pelvic floor symptoms and possible complications for any kind of vaginoplasty (Level # IV Grade D) Vaginoplasty-comprised of vulvoplasty, penectomy, orchiectomy and vaginal canal creation-aims at obtaining an aesthetically pleasing and functional genital complex, vulva and neo-vagina, with adequate depth. The vaginal canal is created between the rectum and bladder, and lined with penile skin- optionally modified with skin grafts, urethral mucosa or scrotal flaps-skin grafts-only, bowel segments or peritoneum. The clitoris is formed by the dorsocentral part of the glans penis, the clitoral hood is formed either from the prepuce or with penile skin. Urethral grafts may aid in vaginal lubrication and sensitivity. The penile-inversion vaginoplasty is currently considered the gold standard. Studies show that penile-inversion vaginoplasty is associated with satisfaction with aesthetics and function., (See below 5.3.2). Indications for vulvoplasty (or zero-depth vaginoplasty) include patient preference or extensive morbidity, for example, a history of rectal fistula. Counselling is strongly recommended to minimize the risk of future regret. Sexologists and pelvic floor physical therapists may counsel patients on dilation and aid in reducing voiding difficulties, which are not related to meatal stenosis. Consultation should preferably be commenced prior to surgery, and continued postoperatively. The sexologist may address issues regarding changing sexual function, for example; in, phantom pains, sexual stimulation and arousal.84, 85, 86 Possible complications of vaginoplasty are perforations and fistulae, haemorrhage and possible future secondary corrections. Secondary corrections are dependent on patient preference and may include resection of residual spongiosum, labiaplasty, clitoral repositioning, correction of the meatus or introitus and vaginal depth augmentation.

Sexual Wellbeing After Vaginoplasty

Sixty-one studies reported outcomes on sexual wellbeing following vaginoplasty, available in Table 2.,79, 80, 81,,,, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141 Postoperative genital sensitivity- defined as clitoral sensation, orgasmic sensation and genital sensation-was conserved in almost every patient.,,,,,,,,,,, Subjective arousal and desire were similarly experienced by a majority (79,1%) of postsurgical women.,,,,,
Table 2

Sexual wellbeing following vaginoplasty

StudyDesignLoESample sizeAge rangeSexual topicsMethods/ToolsOutcomes regarding Sexual Wellbeing
Amend et al 2013, Surgical reconstruction87Outcome measures313 AMAB20–54Intercourse, satisfaction, neo-clitoral sensation, vaginal depth, orgasmSelf-developed structured interview23 (96%) were satisfied with neo-clitoral sensitivity, which led to orgasm.Neo-clitoral sensation was excellent in 18, good in 5, and unsatisfactory in 1. Eight (33 %) had engaged in intercourse, without the need for lubrication. None experienced intravaginal hair growth or loss of vaginal capacity.
Blanchard et al 1983, Vaginoplasty outcome88Outcome measures322 AMABOrgasm, intercourse, self-reported depth adequacy, pain/discomfort during sex, discomfort after sex, frequency of sex, sexual orientationStructured interview, pelvic exam19 (86,4%) had intercourse at least once: 8 experienced no pain, 2 did always, 5 did initially or after a period of sexual inactivity, 4 did slightly. 3 experienced discomforts after sex
Bouman et al 1988, Sex reassignment89Outcome measures476 AMABNo dataSexual intercourse, satisfaction during sex, neo-vaginal dimensions,Chart review3 had complaints due to small vaginal diameter, one was unable to perform receptive vaginal sex. 30 had intercourse with men, 11 with men, 15 had not.
Bouman et al 2016, Patient-Reported90Follow-up study431 AMAB18–45Vaginal intercourse, neo-vaginal dimensions, sexual arousal, sexual feelings, orgasm, desire, lubrication, satisfactionFemale Sexual Function Index, Female Genital Self-Image Scale, Short Questionnaire for Self-Evaluation of Vaginoplasty, Amsterdam Hyperactive Pelvic Floor Scale—Women21 were sexually active, 16 had sex more than once. Every participant experienced sexual arousal. 84 % could reach orgasm, 4% could not, and 12% had not tried.
Brotto et al 2005, Psychophysiological and91Prospective cross-sectional study315 AMAB21–65Thoughts/desire, Frequency of sexual activity, receptivity/initiation, relationship satisfaction, problems affecting sexual function, sexual arousal, non-genitalphysical arousal, genital arousal, pleasure from direct genital stimulation, orgasm (eg, clitoral stimulation,intercourse, vibrator use, fantasy), satisfaction with orgasmicfunction, dissatisfactionor distress, effects of erotic stimuli, objective arousal: using a vaginal pulse amplitudeSelf-developed questionnaire during Vaginal pulse amplitude (VPA), Brief Index of Sexual Functioning for Women (BISF-W); Detailed Assessmentof Sexual Arousal (DASA);4 were sexually active, 6 were able to achieve orgasm. 10 were satisfied with their orgasmic function, 3 (20%) dissatisfied or distressed.
Buncamper et al 2015, Aesthetic and79Retrospective cross- sectional survey449 AMAB29–53Sexually activity, desire, arousal, lubrication, orgasm, satisfaction, comfort, sexual intercourse, neo-vaginal dimensions, sexual feelingsFemale Sexual FunctionIndex (FSFI), Amsterdam Hyperactive Pelvic Floor Scale-Women (AHPFS-W), Female Genital Self-Imaging Scale, short questionnaire for self-evaluation of vaginoplasty36 were sexually active, 27 had attempted intercourse (3 of those tried but were unable). 83.7% had reached orgasm, 10.2% had not, 6.1% had not tried. Orgasmic sensation was equal in 22.4%, less in 28.6%, more in 46.9% and was missing in 2%, compared to prior to vaginoplasty. Provoked vulvodynia was scored with a mean of 1.33 (SD 0.75; 5-point scale from never - very often). Self-reported sexual arousal was present in 44.
Buncamper et al 2017, Penile Inversion92Group comparison4100 AMAB18–68Sexually activity, desire, arousal, lubrication, orgasm, satisfaction, comfort, sexual intercourse, neo-vaginal dimensions, sexual feelingsFemale Sexual FunctionIndex (FSFI), Female Genital Self-Imaging Scale42 had been sexually active in the last 4 weeks. Median score for vaginal functionality: 8 (range 2–10; 1–10 scale, 10 being better; n = 45).
Cardoso da Silva. et al 2016, WHOQOL-10093Follow-up study447 AMAB16–54Marital status, sexual activityWHOQOL-1005 were in a stable relationship, 42 were not.
Cocci et al 2019, Male-to-female138Outcome measures494 AMABM 29.5 yIntercourse, erogenous sensitivityNot specified81 (86.1%) had intercourse. Erogenous sensitivity during dilatation, intercourse ormasturbation was present in 78 (82.9%).
Collyer et al 2002, Patient satisfaction94Outcome measures457 AMAB21–35Orgasm, sexual satisfactionSelf-developed questionnaire34 patients were more sexually satisfied post-surgery; 17 patients had no change; 4 patients were less satisfied.
di Summa et al 2019, Colic-based139Outcome measures443 AMAB22–69Satisfaction with the appearance/dimensions of the genitals, satisfaction with genital function (ing), orgasm (clitoral, vaginal or both), difficulties achieving orgasm, dyspareuniaRetrospective chart review, custom questionnaireOf n = 2810 (35.7%) was very satisfied with sexual functioning, 14 (50%) satisfied, 4 (14.3%) unsatisfied, none very unsatisfied.25 (89.3%) was satisfied or very satisfied with vulvar appearance, 3 (10.7%) unsatisfied, none very unsatisfied.
Djordjevic et al 2011, Rectosigmoid vaginoplasty84Outcome measures427 AMAB59 women18–57Vaginal dimensions, mucous production, sexual satisfaction, sexual activity, time till first intercourse, painFSFI, interviewSexual function was rated satisfactory in 21, 6 were unsatisfied. 73 individuals of the entire cohort were sexually active, separate results not provided. 27 experienced temporary mild bleeding and dyspareunia.
Eldh et al. 1993, Construction of95Outcome measures420 AMABNo dataOrgasm, sexual function, clitoral sensation, intercourseChart review20 could reach orgasm through masturbation or intercourse. 19 (95%) were pleased with their neo-clitoral sensation, 1 (5%) had no sensitivity.
Freundt et al 1993, A modified96Outcome measures423 AMAB16–52Sexual relations, vaginal function, sexual satisfaction, intercourseStructured interview, pelvic examination5 had regular intercourse, 4 women occasionally, 1 did not. Sexual satisfaction was rated good by 2, satisfactory by 2, doubtful by 5, and unsatisfactory by 1. 2 were satisfied with sex life (20%), 4 were neutral, and 4 dissatisfied.
Giraldo et al. 2004, Corona glans97Outcome measures416 AMAB,20–41OrgasmChart review16 were able to achieve orgasm.
Goddard et al. 2007, Feminizing genitoplasty98Outcome measures4233 AFAB, 70 (follow-up)19–76Clitoral sensation, sexual arousal, vaginal dimensions, intercourse, orgasmTelephone questionnaireOf 70 with follow-up, 64 had a neo-clitoris and 62 a vaginal canal: 14 had regular intercourse. 31 could reach clitoral orgasm.Of 183 with neo-clitoral formation: neo-clitoris was sensitive in 158, insensitive in 5, NA in 20. 4 experienced painful or uncomfortable clitoral sensations.
Hess et al 2016, Modified preparation99Follow-up study496 AMAB19–62Neo-clitoral sensation, orgasmSemi-quantitative grading of neo-clitoral sensitivityAssessment of sensitivity by brushing over the clitoris with a brush, and pallesthesia by placing a 64 Hz tuning fork on the clitoris. A semi quantitative scoring system was formed by accumulating both: grade 0, no tactile sensation and complete pallanesthesia; grade 1, reduced pallesthesia and no tactile sensation; grade 2, intact pallesthesia and reduced tactile sensation; grade 3, complete pallesthesia and tactile sensation.n = 79: 11 had grade 1, 12 grade 2, and 56 grade 3. After second-stage (cosmetic corrections).n = 73: 59 could reach orgasm, 7 could not despite trying, 7 (9.6%) had not tried.
Hess et al 2018, Sexuality after140Follow-up study4119 AMAB16–68Sexual orientation, intercourse, frequency of sex, orgasm, orgasm frequency and sensation, satisfaction with clitoral sensitivity, satisfaction with the appearance/dimensions of the genitals, satisfaction with sex life, pleasurability of sex, sexual arousalUnspecified questionnaire33.7% were heterosexual, 37.6% lesbian, and 22.8% bisexual.67 (56.3%) did not have regular intercourse. Of those who had sexual intercourse, 55.8% rated orgasm more intense following GAS, 20.8% who felt no difference.73.9% were satisfied with neo-clitoral sensitivity, and 67.1% with vaginal depth.Of n = 88: sexual activity was always pleasurable for 31 (35.2%), sometimes pleasurable for 44 (50.0%), and never pleasurable for 13 (14.8%).
Imbimbo et al 2009, A report from100Outcome measures4163 AMAB21–59Sexual activity, type of sexual activity, orgasm, masturbation, Satisfaction with sexual life, vaginal dimensionsTelephone questionnaire124 were sexually active: 60 had receptive vaginal sex, 75 receptive anal sex. 32 had masturbated. Satisfaction with sexual life post-surgery was improved in 75% and worsened or unchanged in 25%.
Jarolim et al 2009, Gender reassignment101Outcome measures4129 AMAB18–54Neo-clitoral erogenous sensation, orgasm, lubricationChart reviewOf n = 98: 92 (94%) had erogenous sensitivity of the neo-clitoris had. 64 (65%) reached orgasm 3 mo., some with urethral secretions,which provided lubrication.
Kanhai et al 2016, Sensate vagina102Outcome measures450 AMAB19–65Erogenous sensation in both clitoral pediclesChart review46 (92%) experienced erogenous sensitivity and 41 (82 %) sexual sensations in the clitoris. 44 (88%) experienced erogenous sensitivity and 31 (62 %) sexual sensitivity of the sensate pedicled spot.
Jiang et al 2018, Does depth matter81Outcome measures430 AMAB28–74Relationship status, orgasm, sexual activity.Case-seriesOf n = 14: 4 (29%) could achieve orgasm, 3 (21%) could not. 7 (50%) were not sexually active.Of n = 30: 17 (57%) were married or in a stable relationship, 13 (43%) were not.
Karim et al 1991, The importance of103Outcome measures413 AMAB23–51Swelling and narrowing of vagina during sexual arousalChart review10 experienced vaginal swelling and narrowing during sexual arousal, none did after removal of the corpora spongiosa and cavernosa, none did after removal of the tissue.
Kim et al 2003, Long-term results104Outcome measures428 AMAB22–50Vaginal dimensions, sexual intercourse, lubricant use, pain during intercourse, orgasm, vaginal bleeding during intercourseCross-sectional study22 (78.6%) had intercourse: 1 experienced abdominal pain and 2 vaginal bleeding during intercourse, and 19 could reach orgasm during intercourse.
Kim et al 2017, Is Rectosigmoid105Outcome measures444 AMAB29 vaginal agenesis8 femalepseudohermaphroditis3 gynaecologic malignancies after radical pelvic surgery23–47Sexual intercourse, orgasmChart review79 (94%) had intercourse: 72 experienced orgasms, 2 had mildintermittent abdominal pain, 6 long-lasting abdominal pain, and 6 a small amount of vaginal bleeding after intercourse.
Krege et al 2001, Male-to-female106Follow-up study466 AMAB20–57Sexual intercourse, problems during intercourse, recurrent bleeding after intercourse, clitoral orgasm, vaginal dimensionsSelf-developed questionnairen = 31 with follow-up: 27 (87%) could reach clitoral orgasm, 18 (58.1%) had intercourse, 8 (25.8%) had problems during intercourse (1 swelling of remnants of the corpus spongiosum; 1 problem intravaginal suture line; 2 pains during intercourse; 1 recurrent bleeding after).
Lawrence et al 2003, Factors associated55Follow-up study4232 AMAB19–72Vaginal dimensions, vaginal lubrication, vaginal discharge, sensation to touch at the vaginal opening, sensation to touch deep in the vagina, vaginal pain with penetration, vaginal erotic sensation, clitoral touch sensation, clitoral erotic sensation, clitoral pain, sexual attraction, sexual experience, arousalSelf-developed questionnaireThe number of surgical complications was negatively correlated, and functional results were positively correlated with the absence of regret regarding vaginoplasty. The amount of psychotherapy and the number of complications were negatively, and functional results were positively correlated with happiness with the results of vaginoplasty.
Lawrence et al 2005, Sexuality before107Follow-up study4232 AMAB19–72Sexual orientation, number of sexual partners, frequency of sexual activity, stable partnered relationships, sexual arousal to cross-dressing or cross-gender fantasy, frequency and characteristics of orgasm after GASSelf-developed questionnaireOf n = 226: 76% had postsurgical sexual experiences (28% had mostly female partners, 38% mostly male, 25 % bisexual).Of n = 226: 214 (95%) were sexually active prior to surgery, 12 (5.3%) were not. 72% had mostly female partners, 8% mostly male, 15% bisexual.Of n = 227, 217 (95.6%) had masturbated: 82 (36%) almost always orgasm during masturbation, 27 (12%) > half the time, 33 (15%) did < half the time, 34 (15%) rarely, 41 (18%) never, and 10 (4%) NA.Of n = 217: orgasm prior to and after surgery was almost identical for 4 (2%), very similar for 19 (9%), somewhat similar for 53 (24%), slightly similar for 52 (24%), entirely different for 57 (26%), NA for 32 (15%) .Of n = 218: orgasm after surgery was much more pleasurable for 65 (30%), somewhat more pleasurable for 45 (21%), about as pleasurable for 35 (16%), somewhat less pleasurable for 35 (16%), much less pleasurable for 8 (2%), NA for 30 (14%).Of n = 217: 52 (24%) almost always released fluids during orgasm, 22 did > half of the time for 22 (10%), 17 (8%) did < half of the time, 29 (13%) did rarely, 40 (18%) never, and 57 (26%) NA.
Lawrence et al 2006, Patient-reported complications85Follow-up study4232 AMAB19–72Vaginal dimensions, vaginal lubrication, vaginal discharge, sensation to touch at the vaginal opening, sensation to touch deep in the vagina, vaginal pain with penetration, vaginal erotic sensation, clitoral touch sensation, clitoral erotic sensation, clitoral pain, sexual attraction, sexual experience, arousal, frequency of orgasmSelf-developed questionnaireMean rating on 0–10 scale, 10 being better, were: 7.8 (SD 2.4) for overall happiness with genital sexual function after GAS; 4.4 (SD 2.8) for vaginal lubrication; 7.1 (SD 2.4) for mean rating for pain with vaginal penetration.Frequency of achieving orgasm was significantly associated with overall happiness with sexual function. Individuals who could never orgasm were significantly less happy with their sexual function than others.
LeBreton et al 2017, Genital Sensory108Outcome measures328 AMAB25–60Genital sensitivity, overall satisfaction (patient's satisfaction with the appearance of their genitals, sexual functioning, and clitoral sensitivity), frequency of sexual activities (masturbation, mutual masturbation, vaginal intercourse, anal stimulation, anal intercourse, and oro-genital stimulation)orgasm frequency with each of these activities.Genital sensitivity: Semmes-Weinstein monofilaments (light touch), vulvalgesiometer (pressure), vibralgic 4 device (vibration),questionnaire developed by Lothstein and Shinar, self-developed questionnaire, Derogatis Fantasy Scale.Subjective clitoral sensation was not statistically significantly correlated with sexual satisfaction.Detection thresholds for light touch showed the highest sensitivity on the neck, followed by the anus, abdomen, clitoris, labia minora and then the vaginal opening. Detection thresholds for pressure showed the highest sensitivity on the neck, followed by the clitoris, anus, abdomen, labia minora and the vaginal opening. Detection thresholds for vibration showed the highest sensitivity on the clitoris; followed by the labia minora; the neck; the abdomen; and the vaginal opening and anus.Frequencies of sexual activities ranged from: 0 = N.A.; 1 = < 1/y, 2 =< 1/mo; 3= 1/mo; 4 = 2/mo; 5 = 1/wk; 6 = several times/week; 7 = 1/day; 8 = >1/d.20 (80%) had experienced orgasm. Mean frequencies of achieving orgasm prior to and after having GAS, respectively, were 0.90 (SD 1.38) and 0.56 (SD 1.36) for masturbation, 0.50 (SD 1.47) and -0.24 (SD 1.27) for mutual masturbation, 1.00 (SD 1 .29) and -0.12 (SD 1.09) for vaginal intercourse (penetrative and receptive, respectively), -1.18 (SD 1.30) and -0.16 (SD 1.52) for receptive oral sex, -0.14 (SD 1.36) and -0.36 (SD 1.15), and -0.05 (SD 1.47) and 0.08 (SD 1.04). Prior to GAS: mean frequency of receptive anal sex was 3.20 (SD 2.63), 2.40 (SD 2.71) for insertive vaginal sex, 2.32 (SD 2.75) for receptive oral sex, and 3.20 (SD 2.48) for receptive anal stimulation.Following GAS: mean frequency of receptive vaginal sex was 3.44 (SD 2.49), 2.04 (SD 2.54) for receptive anal sex, 3.48 (SD 2.45) for receptive oral sex, and 2.48 (SD 2.69) for receptive anal stimulation.The difference between pre- and postoperative frequency of receptive oral sex was statistically significant.
Lindemalm et al 1986, Long-term109Evaluation of GAS413 AMAB27–62Sexual adjustment, sexual function, libido, sexual activity, orgasm, partner relationsSemi structured interview, chart reviewOf n = 12: 11 (92%) were sexually active prior to GAS, 1 (8%) was not. Following GAS, 10 (77%) were sexually active. Orgasm prior to GAS: 9 (69.2%) could, 1 (7.7%) could not, unclear for 3 (23.1%).Orgasm after GAS: 6 (46.2%) could (2 with ejaculation), 6 (46.2%) could not, unclear for 1 (7.6%).Strength of libido prior to GAS was low for 5, high for 6, NA for 2. Following GAS: low for 7 (1 of which previously high; 2 NA), moderate for 1 (previously low), high for 5.
Lindemalm et al 1987, Prognostic factors110Evaluation of GAS413 AMAB27–62Sexual adjustment, libido, sexual activitywith partner, number of partners, orgasm, object choice, partner relationsRetrospective rating of interviewThe following outcomes prior to GAS were associated with fair or good overall sexual adjustment after GAS: high sexual activity with a partner, strong libido, intercourse with women, and bisexual experience. High frequency of masturbation was not associated with good adjustment.
Manrique et al 2018, Gender-Confirmation111Evaluation of rectosigmoid vaginoplasty415 AMAB18–32Sexual functionRetrospective chart review, Female Sexual Function Index (FSFI), Female Genital Self-Image Scale (FGSIS)One (6.7%) had by narrowing at the introitus, which required intervention. The mean Female Sexual Function Indexscore was 28.6 (range, 24–31). Every individual achieved normal sexual function (FSFI ≥ of 25)
Mate-Kole et al 1990, A controlled study112Outcome measures440 AMAB (20 postop, 20 preop)21–53Sexual interest, sexual relationshipsChart reviewSexual interest during follow-up of 2 years for n = 20 following GAS was unchanged for 4, 15 were more active, none were less active. Sexual interest for n = 20 awaiting surgery remained unchanged for 17, 0 were more active, 3 were less active.
Morrison et al 2015, Long-Term Outcomes113Outcome measures483 AMAB36–78Dyspareunia, need for lubricant, mucorrhea, orgasmic capacity, sexual functionPhone interview; chart reviewOf n = 44: 43 (98%) were able to orgasm. Of n = 34: 13 (38%) experienced dyspareunia. Of n = 27: 7 (26%) needed lubrication during intercourse. Average rating for satisfaction for n = 24 was 4.24 (1–5 scale).
Mukai et al 2017, Vaginoplasty with114Outcome measures415 AMABM 34.2 (SD 4.0)Intercourse, pain, vaginal dimensionsChart review14 (93.3 %) had intercourse. 1 (6.7%) experienced discomfort during intercourse, because of neovaginal depth of 5–6 cm.
Papadopulos et al 2020, Psychological Pathologies115Follow-up study447 AMAB18–57Improvement of sex life, sexual orientation, change in sexual preferenceCustom questionnaire29 (61.7%) experienced an improvement of sex life following GAS.Prior to surgery: 12 (25.5%) were heterosexual, 22 (46.8%) homosexual, 11 (23.4%) bisexual, and 2 (4.3%) other. Following surgery n = 46, 15 (32.6) were heterosexual, 10 (21.7%) were homosexual gay, 21 (45.7%) were bisexual.
Papadopulos et al 2017, Combined vaginoplasty116Follow-up study440 AMABM 38.6 (SD 12.6)Vulvar sensitivity, vaginal dimensionsChart review and follow-upMost women reported normal labial and vaginal sensitivity, and strong clitoral sensitivity.
Perovic et al 2000, Vaginoplasty in117Outcome measures489 AMAB18–56Orgasm, vaginal sensitivity, vaginal moisture, intercourse, vaginal dimensionsInterview73 (82%) had orgasmed, 69 (79%) were having intercourse. Presence of vaginal moisture was satisfactory for 71 (80%) and unsatisfactory for 16 (18%)
Raigosa et al 2015, Male-to-Female118Outcome measures460 AMAB19–50Frequency and quality of intercourse, orgasm, vaginal dimensions, clitoral sensationInterview (direct questioning during follow-up)52 (86%) had regular intercourse. Clitoral sensitivity was acceptable and led to orgasm for all participants.
Reed et al 2015, Non-grafted Vaginal119Outcome measures418 AMABNo dataVaginal dimensions, sexual functionFSFI and clinical examinationOf n = 10: FSFI domain scores (lubrication 3,7; desire 3,5; arousal 4,0; orgasm 3,9; satisfaction 3,6; pain 4,7) were ≥ mid-range. Average total score was 23.4 (r 2–36).
Rehman et al 1999, The reported sex120Outcome measures428 AMAB18–44QoL, sexual orientation, sexual activity, type of sexual contact (oral, anal, vaginal, other), sexual satisfaction, orgasm (ability and importance), lubricant use, reasoning for sexual inactivityInterview, self-developed questionnaire15 (53.6%) had intercourse, all had some degree of pain during sex and all were using some form of lubricant. 7 (25%) had masturbated. 14 (50%) reported satisfaction from sexual activities and experienced orgasm most of the time, quality and intensity of orgasms were better postoperatively. 15 (53.6%) could orgasm, 7 (25%) orgasmed infrequently and 6 (21.4%) could not orgasm.
Rehman et al 1999 Formation of121Outcome measures410 AMAB23–60Clitoral sensitivity, QoL, sexual orientation, sexual activity, type of sexual contact (oral, anal, vaginal, other), sexual satisfaction, orgasm (ability and importance), lubricant use, reasoning for sexual inactivityInterview, self-developed questionnaireEvery individual had intercourse and reported satisfactory sexual activities. 9 (90%) could orgasm (2 experienced neo-clitoral necrosis, 1 one could not achieve orgasm). Clitoris sensitivity was good with sensitivity to touch, vibration and light pressure in 8 (80%).
Salgado et al 2018, Primary Sigmoid122Outcome measures412 AMABM 47 (SD 15.4)Vaginal dimensions, reported sensation, intercourse, satisfaction with depth, odour and excessive secretionsChart review5 (42%) had intercourse and reported satisfaction with vaginal depth and pleasurable sensitivity. None experienced malodour or excessive secretions.
Schroder et al 1999, New women123Outcome measures417 AMAB35–58Orgasm, masturbation, sexual fantasies, intercourse, relationship status, sexual orientation, sexual satisfaction, genital and breast sensitivity, arousal, sexual desirePostoperative Male-to-Female Questionnaire (Carroll & Schroder, 1993a), New Woman's Gynaecological Index (NWGI) (Schroder, 1993), Stress Inventory (Carroll, 1985),Postoperative Male-to-Female Interview (Carroll & Schroder, 1993b), vaginal plethysmographyMean self-reported rating of sexual satisfaction was 5.4 (0–10 scale, 10 is better).11 (64.7%) could orgasm through masturbation (8 with ease, 3 with difficulty): 5 achieved multiple orgasms, and 5 ejaculated.Of n = 16 sexually active (approximately half had intercourse): 9 orgasmed during partnered activity (4 through penile-vaginal penetration, 3 through masturbation with a partner present).
Seyed-Forootan et al 2018, Autologous Fibroblast124Group comparison/follow-up study424 AMABFibroblast: 28 SD 4yAmnion: 32 SD 3yVaginal dimensions, secretions, intravaginal sensitivity, orgasm, intercourse, satisfaction with intercourseSelf-developed questionnaire, interview, clinical examination of vaginal dimensionsNeo-vaginal sensitivity and lubrication was good for everyone. 18 (75%) had sexual experiences: 93.7% of the fibroblast and 87.5% of the amnion group were satisfied with orgasm and intercourse.
Sigurjónsson et al 2017, Long-Term Sensitivity125Outcome measures422 AMAB23–63Clitoral sensitivity, orgasm, sexual dysfunctionSemmes-Weinstein monofilaments, Bio-Thesiometer, self-developed scaleAverage clitoral tactile thresholds were 12.5 g/mm2, average vibration threshold was 0.3 m. Surgical complications were not associated with diminished clitoral sensitivity or orgasmic capacity.
Soli et al 2008, Male to female126Outcome measures415 AMAB21–60Orgasm, clitoral sensitivityInterview, self-developed questionnaire7 (46.7%) experienced some form of climax during intercourse. Clitoral sensitivity was present and pleasant for every individual, and was present during digital examination by the authors.
Stanojevic et al 2007, Sacrospinous ligament127Outcome measures462 AMAB18–58Ability to perform intercourseChart review42 (76%) had intercourse.
Stein et al 1990, Follow-up observations128Follow-up study422 AMAB20–49Orgasm, vaginal intercourse, pain during intercourse,need for lubricantsInterview, physical examination2 (14.3%) had never orgasmed, 6 (43%) seldom, 2 (14.3%) usually, NA for 4 (28.6%). Orgasm was not at all important for sexual satisfaction for 3 (21.4%), somewhat important for 6 (42.9%), very important for 1 (7.1%), NA for 4.7 (31.8%) had intercourse: 1 (14.3%) used lubricants always, 3 (42.9%) often, 1 (14.3%) never, unknown for 2 (28.6%).Of n = 9: 6 (66.7%) had intimate lovers prior to GAS, 3 (33.3%) did not.
Tavakkoli Tabassi et al 2014, Fold-back129Outcome measures4112 AMABM 25.8 (SD 3.3)Satisfaction with functionChart review96 (85.7%) were satisfied with the appearance and function, 16 (14.3%) were dissatisfied (10 due to depth or stenosis, 6 due to aesthetics).
Thalaivirithan et al 2018, Application of embryonic130Outcome measures430 AMAB21–42Satisfaction with sexual function, frequency of sexual activities (oral, anal), orgasm, sexual satisfactionChart review26 (86.6%) could orgasm, 30 (100%) had intercourse. Frequency of receptive, oral sex increased and anal sex decreased significantly following GAS.Satisfaction with sexual function and the appearance of the labia, vulva and clitoris was good-very good for 98% (5-point scale, unsatisfactory-very good).Sexual satisfaction was statistically (positively) correlated with vaginal function and depth, clitoral sensation, appearance of the vulva/labia minora, and natural lubrication and negatively correlated with depression scores.
Toolenaar et al 1993, The occurrence of131Cross-sectional study411 AMAB 6 women with MRKHSAMAB: 22–48MRKHS: 19–28Intercourse, lubricantSelf-developed questionnaire, clinical examination14 (82.4%) had regular intercourse, 3 (17,6%) did not have a sexual partner. 15 (88,2%) made use of lubricants. 13 (76.5%) experienced white discharge, 15 (88,2%) slight blood loss (6 following intercourse, 9 spontaneously). 3 experienced vaginal cramping (1 solely following sex).
van der Sluis et al 2016, Long-Term132Outcome measures424 AMAB22–73Intercourse, adequacy of vaginal dimensions, sexual arousal, orgasm, desire, lubrication, sexual satisfaction, discomfortFemale Sexual Function Index (FSFI), Amsterdam Hyperactive Pelvic Floor Scale for Women, (AHBBS) Female Genital Self-Imaging Scale (FGSIS), self-developed questionnaire8 (89%) had intercourse, 1 had never. Mean FSFI satisfaction domain score was 4.2 (SD 1.3), mean score for orgasm 4.0 (SD 2.2). 8 (89%) had performed (frequent) penetrative intercourse, orgasm was possible through direct neo-clitoral stimulation.8 (89%) had intercourse frequently, depth was adequate. 1 did not have intercourse (identified as asexual). Sexual arousal was possible, orgasm could be reached through neo-clitoral stimulation.Mean rating for neovaginal functionality was 7.3 (SD 1.8; 1–10 scale), appearance was 7.4 (SD 1.9)
van der Sluis et al 2016, Morphological spectrum133Outcome measures426 AMAB19–52Sexual activity (type of activity), sexual preference, lubricant use, condom use, vaginal symptoms (discharge, odour, pain)Self-developed questionnaire, clinical examination (biopsies, vaginal swabs)8 (31%) reported discharge, 4 (15%), 1 (4%) reported tenesmus, 4 (15%) neovaginal pain (3 of which during deep penetration).
Wagner et al 2010, Male-to-female134Outcome measures450 AMAB25–52Satisfaction with vaginal dimensions, orgasm, intercourse, pain during sexSelf-developed questionnaire35 (70%) had achieved clitoral orgasm, 42 (84%) had regular intercourse (2 of which reported pain during intercourse).
Watanyusakul 2019, Vaginoplasty Modifications13Outcome measures4580 AMAB18–65Vaginal depthNot specifiedAverage depth >1 y follow-up was 16.0 cm.
Weyers et al 2009, Long-term assessment135Follow-up study350 AMABM43.06 (SD 10.42)Importance of sex, sexual functioning, relationships (status and quality), sexual preferenceFemale Sexual Function Index (FSFI), serum hormone levels, self-developed questionnaire3 (6%) were not interested in sex. Median score for importance of sex in a relationship was 6 (interquartile range 5–9; 0–10 scale).Mean FSFI total score was 16.95 (SD 10.04). Overall FSFI scores were positively correlated with sexual satisfaction, general health perception and satisfaction with female appearance as perceived by others. FSFI total scores were highest for heterosexual individuals, intermediate for bisexual and lowest for homosexual individuals. There was no correlation between estradiol levels and mode of estrogen administration with testosterone levels and FSFI scores.
Wu et al 2009, Laparoscopic vaginal136Outcome measures411 AMAB67 DSD women7 Cis womenAMAB: M 23.5 (SD 3.8)DSD: M 24.7 (SD 4,6)Cis: M 47.8 (SD 4.1)Intercourse (time between surgery and first contact), orgasm, lubrication, satisfaction with sexual life, vaginal dimensions, dyspareunia, bleeding during intercourseChart review, self-developed questionnaire71 (88.8%) was sexually active. More than half reported frequent orgasms, and 90% reported adequate lubrication for intercourse. None reported dyspareunia, use of external lubrication, or mild bleeding during intercourse.
Zavlin et al 2017, Male-to-Female80Follow-up study449 AMAB, 40 with questionnaire resultsM 38.6 (|SD 12.6)Intercourse (satisfaction with), (satisfaction with) orgasmic capacity, orgasm, masturbation, (satisfaction with) clitoral sensitivity, pain during masturbation or intercourse, sexual orientationSelf-developed questionnaireMean scores for satisfaction on 0–10 scale (10 is better) with:orgasm 8.21 (SD 2.47, n = 38); preoperative intercourse 3.29 (SD 2.75, n = 7); postoperative intercourse 6.7 (SD 2.03, n = 23).Mean rating of clitoral sensation was 8.53 (SD 1.93, n = 40), and erogenous clitoral sensation was 8.48 (SD 2.04, n = 40). Mean rating of pain during masturbation or intercourse was 2.33 (SD 2.89; n = 39; 10 is extreme pain).7 (17.5%) engaged in regular intercourse prior to GAS, 57.5% following GAS.
Zavlin et al 2019, Age-Related Differences137Cross-sectional study440 AMAB19-66Sexual orientation, marital status, frequency of intercourse, sexual preference, satisfaction with intercourse, sexually active,Self-developed questionnaireFollowing GAS, younger individuals were mostly attracted to men (52.6%), later-onset individuals mostly to women or both (85.7%). Younger trans individuals were more frequently sexually active (73.7% vs 42.9%).
Sexual wellbeing following vaginoplasty Twenty-four studies discussed whether participants could attain orgasm.,,,,,,,98, 99, 100, 101,,106, 107, 108, 109,,,,,,,, A majority (about 70%) could achieve orgasm,,,,,,,98, 99, 100, 101,,106, 107, 108, 109,,,,,,,,,, whereas less than 10% could not or had not,,,,,,,,,,, 10% had not tried,,,, and another 10% chose ‘not applicable.’ Five studies applied the Female Sexual Function Index (FSFI) and reported a mean orgasm domain score ranging between 2.82–3.9 (scores CIS women without sexual problems 5.1 SD1.1).,,, Finally, Zavlin et al found a mean frequency of achieving orgasm of 6.73 (SD 3.32) during masturbation and 6.52 (SD 3.11) during intercourse. Over half of participants masturbated regularly,,,,,,,,,,144, 145, 146 and every participants had engaged in receptive vaginal activity.,,,,,, Some, however, failed at penetrative sex, either because of short time since surgery, inadequate vaginal dimensions or pain.,,, Reporting on other sexual activities, for example, receptive anal sex,,, and- active and passive- oral sex was limited., Whether GAS brings about a change in sexual activities remains unclear, this data and associations between presurgical and postsurgical sexual activity were not provided.,,,,, Overall sexual satisfaction or satisfaction with sex life (77%),,,,,,,,,,,, satisfaction during sex,,, and satisfaction with orgasmic function was present in a majority of postsurgical individuals., Some studies reported on sexual dysfunction, where sexual wellbeing was mostly defined as a lack of sexual dysfunction. Ten studies discussed pain during receptive vaginal sex in AMAB individuals; one third experienced either pain in or around the introitus, deep or superficial dyspareunia or vulvodynia.,,,,,,,,, Difficulties for AMAB individuals during penetrative sex were described in 10 studies: a third experienced difficulties or were unable to perform receptive vaginal sex, due to inadequate vaginal depth or width.,,,,,,,,

Breast Augmentation

Statement #10 The gender surgeon is advised to suspend breast augmentation in trans individuals AMAB until 12 months of hormone therapy have been completed (Level III Grade C) Statement #11 The gender surgeon is advised to consider fat grafting as available alternative to or extension of implant use in trans individuals AMAB (Level IV Grade C) Statement #12 The gender surgeon should counsel the trans individuals AMAB on risks associated with implant use (Level III Grade B) Feminizing hormone therapy might yield unsatisfactory breast development. Individuals might not reach the final stages of breast development and opt for breast augmentation, which may improve feminine contour, increase subjective feelings of femininity, aid in passability and adjustment to the female gender role, and consequently increase sexual and psychosocial wellbeing. Choice of augmentation technique is dependent on both patient and surgeon's preference. Patients should be counselled on implant type, implant surface and placement. Care must be taken to properly centre the implant under the nipple-areolar complex (NAC) to prevent diverging nipples and wide cleavage., Implant placement more medial of the NAC can be considered in individuals with a laterally placed NAC, or surgical medialization of the NAC can be pursued., Implant use is advantageous in regard to predictability of results. Associated risks, however, are capsular contracture, implant malposition, autoimmune responses and Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Fat grafting provides an alternative to implant use, eliminating the risk of BIA-ALCL. Fat grafting can be done solitary, in conjunction with implant use, as well as during secondary corrections. Breast cancer screening should be performed according to the local guidelines.

Sexual Wellbeing

One study reported on sexual wellbeing following breast augmentation, finding a significant increase in sexual wellbeing four months postoperatively (Table 3).
Table 3

Sexual wellbeing following breast augmentation

StudyDesignLoESample sizeAge rangeSexual TopicsMethods/ToolsOutcomes regarding Sexual Wellbeing
Weigert et al 2013 Patient satisfaction149Follow-up study435 AMAB18,9–62,6Sexual wellbeingBreast-QSexual wellbeing:4 mo post-op: ↑ 34 points12> mo post-op: ↑ 33 points
Sexual wellbeing following breast augmentation

Vocal Feminization Surgery

Statement #13 The Ear, Nose and Throat (ENT) surgeon should consider vocal feminization surgery when treatments with speech-language pathologists have yielded unsatisfactory results in trans individuals AMAB (Level IV Grade D) Consulting an ENT surgeon prior to starting with speech therapy is recommended, to rule out vocal cord anatomy and functioning anomalies. Surgery may be considered if speech therapy yields unsatisfactory results. Surgical results are unpredictable. We found no studies on sexual wellbeing after vocal feminization surgery in AMAB individuals.

Facial Feminization Surgery (FFS)

Statement #14 The gender surgeon should treat secondary facial aspects before beginning structural facial GAS in trans individuals AMAB (Level IV Grade C) Statement #15 The gender surgeon is advised to consider adjustments of the frontonasal-orbital complex, the nose, the lower jaw and the thyroid cartilage when performing FFS in trans individuals AMAB (Level IV Grade C) Secondary or non-skeletal facial aspects, such as hair and hairline, facial hair, skin texture, and the distribution and volume of facial fat can be heavily determined by hormonal influence, generally responding well to hormone therapy, which in itself does not interfere in any way with surgery. In addition, many AMAB will opt to undergo laser facial hair removal or electrolysis. It is therefore preferable to treat the secondary aspects before beginning structural or skeletal facial gender confirmation surgery (at least 12 months before surgery). Obtaining a female bone structure while maintaining male secondary aspects is self-defeating to both the result and the perception of the patient's femininity. The expectations for the results will be more real if the initial anticipation, both psychological and physical, is realistic. Adjustments of the frontonasal-orbital complex, the nose, the lower jaw and the thyroid cartilage are elements of Facial Feminization Surgery (FFS).159, 160, 161, 162, 163. Forehead reconstruction and hairline corrections-approached through a coronal or hairline incision open up the upper face.165, 166, 167, 168 Lower jaw contouring corrects the lower face by reducing the transverse and vertical dimensions of the jaw, softening the angle of the mandible, improving jawline contour and adjusting of the volume, format and position of the chin.169, 170, 171, 172, 173, 174, 175, 176, 177, 178 The midface may be addressed with rhinoplasty. We found no studies on sexual wellbeing after facial feminization surgery (FFS).

Surgical Procedures for Masculinizing GAS

This section addresses different types of masculinizing GAS, with their respective results regarding sexual wellbeing. Decision making is on patient preference and patient specifics.

Mastectomy

Statement #16 The gender surgeon is advised to consider performing a mastectomy in trans individuals AFAB prior to starting living in the desired gender, in selected cases of severe dysphoria and with large volume chests (Level IV Grade D) Masculinizing chest surgery may improve dysphoria, body image, psychological and sexual wellbeing and overall quality of life, and carries importance for AFAB individuals in this regard.,, Excess skin and glandular tissue is excised, whilst preserving subcutaneous fatty tissue to ensure flap vascularity and facilitating an acceptable contour of the chest wall. Techniques include the semi-circular technique, trans-areolar technique, concentric circular technique, free nipple technique with horizontal scar and the inferior pedicled mammaplasty technique, for “Breast size and mastectomy techniques” see Figure 1.,
Figure 1

Breast size, ptosis and skin elasticity in regards to mastectomy techniques. Grade I ptosis correspond with the areola placed on the level of the inframammary crease (IMC), Grade II corresponds with the nipple below the IMC and above the level of the gland, grade III corresponds with the areola below the IMC and below the contour of the gland. Cup size A corresponds with a breast volume of less than 150 cc in individuals with an under bust circumference of 70–75 cm; cup size B corresponds with a volume of 250–299 cc with an under bust of 70–75 cm, cup size C corresponds with 300–349 cc with an under bust of 70–75 cm.,

Breast size, ptosis and skin elasticity in regards to mastectomy techniques. Grade I ptosis correspond with the areola placed on the level of the inframammary crease (IMC), Grade II corresponds with the nipple below the IMC and above the level of the gland, grade III corresponds with the areola below the IMC and below the contour of the gland. Cup size A corresponds with a breast volume of less than 150 cc in individuals with an under bust circumference of 70–75 cm; cup size B corresponds with a volume of 250–299 cc with an under bust of 70–75 cm, cup size C corresponds with 300–349 cc with an under bust of 70–75 cm., The semi-circular technique is applicable for very small breasts. The scar is confined to the lower half of the areola. Limited surgical exposure carries risk of increasing postoperative hematomas. The trans-areolar technique allows for correction of the nipple by nature of the scar placement through the areola, horizontally. This carries increased risk of postoperative hematomas. The concentric circular technique allows for correction of excess skin through an ellipse, or circle shaped, incision. May lead to skin puckering around the areola, areolar widening- due to traction- and nipple necrosis., The horizontal scar and free graft technique allow for correction of very large breasts. It is met with large scars, NAC depigmentation and partial graft loss., The inferior pedicled mammaplasty technique is comparable, whilst transposing the NAC on an inferior pedicle, instead of a free graft. Masculinizing hormone therapy may ameliorate breast cancer risk. Patients should, however, be made aware of residual breast tissue on the entire plane of dissection.

Sexual Wellbeing After Mastectomy

Three studies reported on sexual wellbeing after mastectomy, accessible in Table 4. These publications mostly focused on sexual relationships and quality of sex life. Mastectomy improved quality of life and confidence in social and sexual situations, in both dressed and undressed situations. Reduction of dysphoria, improvement of body image and confidence following mastectomy affected sexual relationships positively.,,
Table 4

Sexual wellbeing following mastectomy

StudyDesignLoESample sizeAge rangeSexual TopicsMethods/ToolsOutcomes regarding Sexual Wellbeing
Esmonde et al 2019What is “Nonbinary”183Outcome measure458 AFAB18–48Sexual orientation, relationship statusRetrospective chart reviewSurgery improved quality of life, sex life, and comfort in physical appearance with and without clothes.
Poudrier et al 2019Assessing Quality of Life184Cross sectional study458 AFAB18–58Satisfaction with sex life, sexual confidence (sexually confident without a shirt, likely to remove shirt for sex), comfortable during sexual activities, sexually attractive in clothes, when unclothedCustom questionnaireMost respondents rated their quality of life and sexual confidence before top surgery as very low. Post-op, quality of life and sexual confidence improved significantly in all domains.
van de Grift et al 2016Subcutaneous Mastectomy38Follow-up study426 AFAB18–59Sexual orientation, sufficiency as sexual partner, pleasure of sexual activitiesAppearance Schemas Inventory Revised, Body Image Quality of Life Inventory (BIQLI), Body Image Scale for Transsexuals (BIS), Multidimensional Body-Self Relations Questionnaire, Rosenberg Self-Esteem Scale, Perceived Effect of Surgery (self-developed)Mastectomy positively influences body image. Positive evaluation of the body and decreased dysphoria during social situations –> increased quality of life and self-esteem.
Sexual wellbeing following mastectomy

Removal of the Female Sexual Organs

Statement #17 The gender surgeon is advised to counsel on intervention options salpingo-oophorectomy, hysterectomy and vaginectomy, dependent on trans individuals AFAB preference (Level IV Grade D) Statement #18 The gender surgeon should advise routine screening, by a general practitioner or gynaecologist, for cervical cancer if the uterus remains in situ in trans individuals AFAB (Level IV Grade D) Indications for hysterectomy include persistent blood loss, dysphoric feelings, unwanted discharge or lubrication, and within the context of GAS with urethral lengthening. Vaginectomy, and subsequent hysterectomy, maybe a required when opting for urethral lengthening, because of higher risks of developing complications. The choice for salpingo-oophorectomy is dependent on patient preference-only. Routine screening for cervical cancer should be continued. Screening for endometrial cancer should be commenced in older patients with vaginal blood loss. Evidence for positive effects of routine screening for ovarian cancer in trans individuals AFAB are lacking. We would therefore not encourage routine screening, currently. Consider counselling on HPV self-sampling to increase testing rates.

Sexual Wellbeing After Removal of the Female Sexual Organs

We found no results of studies on sexual wellbeing in trans individuals AFAB after removal of the female sexual organs.

Metaidoioplasty

Statement #19 The gender surgeon should suggest metaidoioplasty as a variant of one-stage neo-phalloplasty in masculinizing genital GAS in trans individuals AFAB (Level IV, Grade C) Statement #20 The gender surgeon should advise postoperative genital stretching, to prevent genital shrinkage after metaidoioplasty in trans individuals AFAB (Level IV, Grade D) Statement #21 The gender surgeon should engage in shared decision making and counselling in choosing type of genital masculinisation surgery in trans individuals AFAB (Level II Grade D) Statement #22 The gender surgeon is advised to counsel trans individuals AFAB on the specific advantages of a metaidoioplasty being: preservation of sexual arousal, erogenous sensation and spontaneous erections (Level IV Grade D) Statement #23 The gender surgeon is advised to counsel trans individuals AFAB on the specific disadvantagesof a metaidoioplasty being: possible lack of length for penetration or to void standing (Level IV Grade D) Metaidoioplasty can be carried out as a one-stage procedure, with removal of the female sexual organs, optional urethral lengthening, scrotoplasty and testicular implants placement., The majority of the lengthening of the clitoris is achieved through ventral division of the urethral plate. Additional length may be obtained by dividing the clitoral suspensory ligaments., Clitoral length should be sufficient for voiding while standing when urethral lengthening is requested, studies do not report on what is meant by “sufficient”. The technique for urethral lengthening is dependent on patient anatomy and tissue quality, options include pedicled labia minora grafts and buccal mucosa grafts. Having non-overlapping suture lines and covering suture lines with vascularized tissue prevent fistulation.,, Scrotoplasty is achieved through labial tissue, testicular implants can be inserted., Postoperative genital stretching- either manual, vacuum-assisted or withPDE5 inhibitors- may prevent genital shrinking. However, evidences on this topic are poor.,, Choices on genital masculinization surgery are increasingly being made through shared decision-making. The surgeon should inform the patient on the different options (metaidoioplasty and phalloplasty, the techniques available, their advantages and disadvantages, limitations with producing ‘ideal’ results and possible risks and complications.52, 53, 54 Common minor complications are urinary tract infections and bladder overactivity. Minor urethral fistulae and strictures can be managed non-surgically, revision surgery is indicated for major fistulae and strictures,, regenerating vaginal mucosa,,, and displaced or expelled testicular implants.

Sexual Wellbeing After Metaidoioplasty

Sexual wellbeing was reported on in six publications, provided in Table 5.,,,,195, 196, 197 Five of these publications may contain an overlap in study population.,,,, Sexual wellbeing following metoidioplasty Metaidoioplasty provided satisfying aesthetics and positive outcomes regarding sexual wellbeing, sensation, erectile function and orgasm. Sexual arousal, which resulted in erection, and sensation were present in every individual.,,,, A majority of participants had masturbated, which had not resulted in orgasm for everyone,,,, and insufficient length for penetrative sex proved the main disadvantage.,, An average of 10% initially opting for metaidoioplasty, pursued conversion to phalloplasty at a later stage.

Phalloplasty or Total Phallic Construction (TPC)

Statement #24 The gender surgeon should provide trans individuals AFAB the radial free forearm flap (RFFF) phalloplasty as the technique of choice for masculinizing genital GAS in patients desiring a full-size phalloplasty, accompanied by urethral lengthening (Level IV, Grade C) Statement #25 The gender surgeon should be capable to offer alternatives to the free forearm flap (RFFF) in trans individuals AFAB, like: the antero-lateral thigh flap (ALT), pedicled pubic phalloplasty (PP) or latissimus dorsi (LD) phalloplasty as an alternative full-size phalloplasty with or without urethral lengthening (Level IV, Grade C) Statement #26 The gender surgeon is advised to combine a skin flap (RFFF or pedicled superficial circumflex iliac artery perforator flap) for urethral lengthening, when a single-flap reconstruction cannot be accomplished, in trans individuals AFAB (Level IV, Grade C) Statement #27 The gender surgeon should engage in shared decision making and counselling in choosing type of genital masculinisation surgery, in trans individuals AFAB (Level II Grade D) Statement #28 The gender surgeon is advised to counsel, trans individuals AFAB, on the specific advantagesof a phalloplasty being: volume in genital area when dressed, possibility of penetration (Level IV Grade D) Statement #29 The gender surgeon is advised to counsel, trans individuals AFAB, on the specific disadvantagesof a phalloplasty being: cutaneous and erogenous sensitivity can be poor (Level IV Grade D) Total Phallic Construction (TPC) aims at creating a phallus with acceptable aesthetics, a degree of cutaneous and erogenous sensitivity and sufficient bulk to house potential erectile prostheses. Standing urination is achieved through urethral lengthening. Techniques include: the radial free forearm flap, suprapubic pedicled pubic (PP), superficial circumflex iliac artery perforator flap (SCIP), antero-lateral thigh flap (ALT)and the latissimus dorsi flap (LD) techniques. Table 6 shows donor sites, flap types, urethral lengthening options, sensation, advantages and disadvantages of all flaps. The RFFF presents superior aesthetics and functionality, allowing for integrated urethral lengthening,198, 199, 200, 201 compared to other techniques, and is considered “the gold standard” by some. RFFF-TPC is commonly carried out in three stages of six-month intervals: the creation of the phallus and neo-urethra, microsurgically anastomosed; glans- and coronaplasty using a full-thickness skin graft; and potential erectile prosthesis implantation. Proper preparation reduces donor-site morbidity and full-thickness skin grafts result in less scarring and discoloration., Interposition of collagen-matrix, between the recipient site and a split-thickness skin graft, simulates the appearance of a full-thickness skin graft without hair. The pedicled pubic phallus is fashioned from a cutaneous flap that is raised from the inferior aspect of the abdominal wall, allowing for primary closure of the donor site. Both the PP flap and the SCIP flap are Hair-Bearing, have poor cutaneous sensitivity and difficult urethral lengthening. Direct urethral lengthening is carries increased risk of complications, delayed incorporation of a free radial artery based flap bears less complications and is not prone to sacculation. The ALT flap is a reasonable option, established from a pedicled Fascio-Cutaneous flap of the perforating vessels of the vastus lateralis and rectus femoris. Pedicle length is commonly sufficient for tunnelling to the pubic area, obviating microsurgical techniques. A thick fat layer and hair complicate integrated urethral lengthening, often requiring other flaps for urethral lengthening. Cutaneous sensation is moderate due to the presence of one cutaneous nerve within the flap. The donor site is usually covered with split-thickness skin grafts. The LD flap allows for a larger myocutaneous flap based on the thoracodorsal artery and nerve, allowing for primary closure of the donor site. Cutaneous sensation is poor as a single motor nerve is available. Urethral lengthening requires multi-stage buccal mucosa and labia minora flaps.
Table 6

Total phallic construction: donor sites, flap types, urethral lengthening options, sensation, advantages and disadvantages of all flaps

Type of TPRDonor siteType of flapNeo-urethraSensationAdvantageDisadvantage
Radial artery forearm free flap (RAFFF)Non-dominant forearmFree flapDirect possibleSensateGood aestheticsTip-reaching urethral lengtheningSignificant donor-site scarring
Suprapubic pedicled flapLower abdomenPedicled flapStaged radial artery-based flapPoor cutaneous sensitivityOperating time is relatively short Donor site scarring is limited to the abdomenPoor cutaneous sensitivityDifficult urethral lengthening
Superficial circumflex iliac artery perforator (SCIP) flapGroin/flankPedicled flapDirect double SCIP or with another free flapNo dataOperating time is relatively shortDonor site scarring is limited to the abdomenNo data on sensation
Antero-lateral thigh (ALT)Upper legPedicled flapDirect or with another free flapModerate cutaneous sensitivityPedicle length sufficient for tunnellingPatient selection important: subcutaneous fat layerModerate cutaneous sensitivity
Latissimus dorsi (LD)Side of chest under armFree flapIn 2 stages with buccal mucosa graftsPoor cutaneous sensationMinimal donor site morbiditySecond-stage urethral lengthening with buccal mucosa grafts
Total phallic construction: donor sites, flap types, urethral lengthening options, sensation, advantages and disadvantages of all flaps As stated in the metaidoioplasty section choices on genital masculinization surgery are increasingly being made through shared decision-making. The surgeon should inform the patient on the different options (metaidoioplasty and phalloplasty, the techniques available, their advantages and disadvantages, limitations with producing ‘ideal’ results and possible risks and complications.52, 53, 54

Sexual Wellbeing After Phalloplasty

Eighteen studies reported on sexual wellbeing after phalloplasty, provided in Table 7.,,,211, 212, 213, 214, 215 Outcomes for various surgical techniques were often pooled, separate results were rarely provided. Four pairs of studies may have had an overlap in study population. Sexual wellbeing following phalloplasty AFAB = assigned female at birth (transmasculine individual, trans man); AMAB = assigned male at birth (transfeminine individual, trans woman); LoE = level of evidence (oxford centre for evidence-based medicine 2011); MRKHS = mayer rokitansky kuster hauser syndrome. Five studies reported on postsurgical sensation, which was present in 86.3%.216, 217, 218, 219, 220 Most experienced partial sensation, either in the buried clitoral site, the shaft,, the neo-urethra and sensation projecting to the thigh. Postsurgical orgasm was discussed in three studies. Garcia et al and Wierckx et al reported that 92% and 97.8% were able to reach orgasm, respectively, and Van de Grift et al found that orgasmic capacity increased in 18%, was unchanged in 52% and decreased in 26%. Ten studies reported on the possibility of penetrative sex, which ranged between 38.8–85%.,,,,,,,,,

Conclusions

This position statement provides healthcare providers with recommendations that may aid in decision making regarding GAS. Although findings may suggest positive outcomes regarding sexual wellbeing following vaginoplasty, mastectomy, metoidioplasty, and phalloplasty, the overall quality of evidence is still low and most recommendations of this position statement are Level of Evidence C. Not only methods of data gathering and reporting vary, some forms of GAS are not studied at all when it comes to effects on sexual wellbeing. Therefore, we advise more research on the effects of orchiectomy-only, breast augmentation, vocal feminization surgery, facial feminization surgery and the removal of the female sexual organs on sexual wellbeing in trans individuals. In trans individuals AMAB; breast augmentation is mostly studied with a focus on surgical techniques. Data on sensitivity, functioning and sexual wellbeing are lacking. Next to the effects of FFS on sexual wellbeing, further research focusing on separate aspects of FFS is encouraged and necessary. The majority of questionnaires that were applied in evaluating sexual activity after GAS in trans individuals AMAB, were validated for cis women- in heterosexual relationships, who engaged in penetrative sex- only. A substantial portion of aforementioned participants, however, were intimate with women, or did not have sexual relationships. Therefore, the development of specific questionnaires to evaluate the effect of GAS on the sexual wellbeing in trans individuals is needed. In trans individuals AFAB; it is known that mastectomy is a viable option in improving gender incongruence, body image, psychological wellbeing, sexual wellbeing and overall quality of life. Evidence on sexual wellbeing after mastectomy is limited, focussing mainly on quality of sex life and sexual relationships. In masculinizing genital GAS a metaidoioplasty provides a sensate neophallus with the possibility to void standing, erotic satisfaction, and high levels of postsurgical satisfaction, with minimal donor site morbidity. However, there is need for validated questionnaires that can measure functionality, aesthetic appearance and patient satisfaction, to improve objective conclusions. Furthermore, the unique anatomy of the male genitalia and the absence of tissue engineering options, to replace the smooth muscle of the corpora cavernosa and spongiosum, complicate TPC. The absence of comparative studies hampers selection of preferential techniques. Functional outcomes and patient satisfaction are difficult to comment on because of the lack of validated questionnaires to assess these outcomes. Long-term effects of GAMI and GAS should also be studied, where after consensus on cancer screening in trans individuals should be formed, especially in hormone sensitive cancers or organs. Next to the lack of studies on the effects of GAS and GAMI on sexual wellbeing, research on the development of validated questionnaires and patient-reported outcome measures may aid in producing less heterogeneous data. To conclude, heterogeneous methods of data gathering and reporting and missing data on sexual wellbeing after orchiectomy-only, vocal feminization surgery, facial feminization surgery and the removal of the female sexual organs further complicate the ability to draw robust conclusions, together with the lack of studies on the effects of GAS and GAMI on sexual wellbeing, emphasizing the need for future research. Future research on the development of validated questionnaires and patient-reported outcome measures may aid in producing less heterogeneous data. Researchers and clinicians alike should consider exchanging data and actively involve the transgender and gender-diverse community, in a bid to further improve not only surgical care, but trans-related care as a collective.

Statement Of Authorship

Müjde Özer, Sahaand Poor Toulabi, Guy T'Sjoen, Joz Motmans: Conceptualization; Müjde Özer, Sahaand Poor Toulabi: Methodology; Müjde Özer, Sahaand Poor Toulabi: Investigation; All authors: Writing – Original Draft; All authors: Writing – Review & Editing; Guy T'Sjoen, Joz Motmans: Supervision.
  200 in total

Review 1.  Testosterone Replacement Therapy for Sexual Symptoms.

Authors:  Giulia Rastrelli; Federica Guaraldi; Yacov Reismann; Alessandra Sforza; Andrea M Isidori; Mario Maggi; Giovanni Corona
Journal:  Sex Med Rev       Date:  2019-02-22

2.  The trans-sexual syndrome in homosexual males.

Authors:  K Freund; R Langevin; Y Zajac; B Steiner; A Zajac
Journal:  J Nerv Ment Dis       Date:  1974-02       Impact factor: 2.254

3.  The outcome of sex reassignment surgery in Belgrade: 32 patients of both sexes.

Authors:  Z Rakic; V Starcevic; J Maric; K Kelin
Journal:  Arch Sex Behav       Date:  1996-10

4.  Modified Preparation of the Neurovascular Bundle in Male to Female Transgender Patients.

Authors:  Jochen Hess; Yasmine Hess-Busch; Janine Kronier; Herbert Rübben; Roberto Rossi Neto
Journal:  Urol Int       Date:  2016-01-19       Impact factor: 2.089

5.  Gender-Confirming Vulvoplasty in Transgender Women in the Netherlands: Incidence, Motivation Analysis, and Surgical Outcomes.

Authors:  Wouter B van der Sluis; Thomas D Steensma; Floyd W Timmermans; Jan Maerten Smit; Kristin de Haseth; Müjde Özer; Mark-Bram Bouman
Journal:  J Sex Med       Date:  2020-05-17       Impact factor: 3.802

Review 6.  [Adverse effects if smoking on healing of bones and soft tissues].

Authors:  J M Hoogendoorn; R K J Simmermacher; P P A Schellekens; C van der Werken
Journal:  Unfallchirurg       Date:  2002-01       Impact factor: 1.000

7.  Total phalloplasty using a musculocutaneous latissimus dorsi flap.

Authors:  Sava V Perovic; Rados Djinovic; Marko Bumbasirevic; Miroslav Djordjevic; Petar Vukovic
Journal:  BJU Int       Date:  2007-10       Impact factor: 5.588

8.  Contribution of androgen receptor sensitivity to the relation between testosterone and sexual desire: An exploration in male-to-female transsexuals.

Authors:  E Elaut; V Bogaert; G De Cuypere; S Weyers; L Gijs; J-M Kaufman; G T'Sjoen
Journal:  J Endocrinol Invest       Date:  2009-07-20       Impact factor: 4.256

9.  A new protocol for complete phalloplasty with free sensate and prelaminated osteofasciocutaneous flaps: experience in 37 patients.

Authors:  Juergen Schaff; Nikolaos A Papadopulos
Journal:  Microsurgery       Date:  2009       Impact factor: 2.425

10.  The Bilateral Pedicled Epilated Scrotal Flap: A Powerful Adjunctive for Creation of More Neovaginal Depth in Penile Inversion Vaginoplasty.

Authors:  Tim H J Nijhuis; Müjde Özer; Wouter B van der Sluis; Muhammed Al-Tamini; Ali Salim; Philip Thomas; James Bellringer; Mark-Bram Bouman
Journal:  J Sex Med       Date:  2020-03-20       Impact factor: 3.802

View more
  1 in total

1.  Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors:  E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal:  Int J Transgend Health       Date:  2022-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.